Terapevticheskii Arkhiv

(The TQCC of Terapevticheskii Arkhiv is 3. The table below lists those papers that are above that threshold based on CrossRef citation counts. The publications cover those that have been published in the past four years, i.e., from 2019-06-01 to 2023-06-01.)
Diabetes epidemiology in Russia: what has changed over the decade?65
Comparative analysis of mortality from acute forms of ischemic heart disease during a 15-year period in the Russian Federation and the United States and the factors influencing its formation21
Pulmonary arterial hypertension in Russia: six-year observation analysis of the National Registry21
Clinical efficacy of umifenovir in influenza and ARVI (study ARBITR)20
Markers of dysbiosis in patients with ulcerative colitis and Crohn's disease19
European registry Helicobacter pylori (Hp-EuReg): how has clinical practice changed in Russia from 2013 to 2018 years19
Modern content and improvement of high cardiovascular risk strategy in reducing mortality from cardiovascular diseases18
Neurological disorders in vitamin B12 deficiency17
Spondyloarthritis: modern terminology and definitions16
Current advances in the treatment of gastroesophageal reflux disease: a focus on esophageal protection12
Rebamipide increases the disaccharidases activity in patients with enteropathy with impaired membrane digestion. Pilot study11
Galactin-3: diagnostic and prognostic value in patients with chronic heart failure10
Diagnosis and treatment of acute low back pain10
The canonical Wnt/β-catenin pathway: From the history of its discovery to clinical application10
Epidemiology of multiple myeloma in city Moscow10
Kagocel in the therapy of influenza and acute respiratory viral infections: Data analysis and systematization from the results of preclinical and clinical trials9
Features of clinical, functional and hemodynamics profile, medical treatment and prognosis evaluation in patients with inoperable chronic thromboembolic pulmonary hypertension and idiopathic pulmonary9
Possibilities of ultrasound research of the diaphragm9
Arterial hypertension and chronic obstructive pulmonary disease: clinical characteristics and treatment efficasy (according to the national register of arterial hypertension)9
Respiratory muscles dysfunction and respiratory diseases8
Rheumatoid arthritis: achievements and unresolved issues8
Comorbidity in gout and hyperuricemia: prevalence, causes, prospects of urate lowering therapy8
Significance of L-carnitine in internal medicine8
Morphologically proved ANCA positive Loeffler’s pancarditis: medical and surgical treatment7
Clinical features of arterial hypertension in men and women (according to the National Registry of Arterial Hypertension)7
Choice of optimal vaccination tactics against pneumococcal infection from immunological and clinical standpoints in patients with chronic obstructive pulmonary disease7
Vitamins in diet of patients with metabolic syndrome7
ANICHKOV study: the effect of combined hypotensive and lipid-lowering therapy on cardiovascular complications in patients of high and very high risk7
Ademethionine in the treatment of fatigue in liver diseases: a systematic review7
Risk factors associated with portal vein thrombosis in liver cirrhosis: A case-control study6
The relationship of hypertriglyceridemia and left ventricular remodeling types in patients with chronic kidney disease6
Hyperuricemia, gout and high cardiovascular risk - how to manage them in clinical practice6
Treatment of candidemia caused by Candida albicans and Candida non - albicans in patients with hematological malignancies6
O.V. Knyazev, A.V. Kagramanova, I.A. Korneeva, K.K. Noskova, S.V. Belousov, A.I. Parfenov6
Role of intestinal microbiota in the formation of non-alcoholic fatty liver disease6
Recent advances in diagnosis and management of atrial fibrillation6
Review of current and future directions of antiviral therapy of influenza and acute respiratory viral infections in Russia6
Comorbidity and polymorbidity of the patient with chronic obstructive pulmonary disease and cardiovascular diseases6
2019 Coronavirus disease (COVID-19): contribution of rheumatology6
Gastroesophageal reflux disease and esophagitis associated with the use of drugs: the modern state of the problem5
Comparative analysis of bile acid spectrum in non-alcoholic fatty liver disease and cholelithiasis5
New opportunities of dual bronchodilation therapy for patients with chronic obstructive pulmonary disease5
Prevalence and prognostic value of gastroenterological manifestations of COVID-19: data from the Russian University Clinic5
Atherosclerosis of peripheral arteries in patients with coronary artery disease and type 2 diabetes mellitus5
Malnutrition: from pathogenesis to current methods for diagnosis and treatment5
Functional state of the small airways in patients with bronchial asthma associated with obesity5
MutYH-associated polyposis5
Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy5
Damage to periarticular soft tissues in real clinical practice: frequency, nature, effectiveness of non - steroidal anti - inflammatory drugs5
The clinical status and treatment options for osteoarthritis in patients with frailty5
The use of Tofacitinib in the treatment of inflammatory bowel disease5
Destruction of the bronchial epithelium in patients with severe asthma according to different patterns of inflammation and cold airway hyperresponsiveness5
Risk - adapted intensive induction therapy, autologous stem cell transplantation, and rituximab maintenance allow to reach a high 7-year survival rate in patients with mantle cell lymphoma4
Efficacy of H. pylori eradication depending on genetic polymorphism of CYP2C19, MDR1 and IL-1β4
Analysis of the impact of vaccination of pneumococcal infection in patients with chronic obstructive pulmonary disease in combination with diabetes4
Eosinophilic inflammation in chronic obstructive pulmonary disease4
Diabetic macroangiopathy4
Clinical and laboratory characteristics of IgG4-realated disease and its diagnostic algorithm4
Micro-RNA as a new biomarker of activity of the cytochrome system P-450: significance for predicting the antiplatelet action of P2Y12 receptor inhibitors4
Risk factors of unfavorable prognosis of chronic hepatitis C4
Glucocorticosteroids for people with alcoholic hepatitis (Cochrane review)4
Iatrogenia in internist practice4
Effect of stress at work on the risk of cardiovascular diseases among the population of 25-64 years in Russia/Siberia (WHO program “MONICA-psychosocial”)4
Glycemia normalization in patients with obesity and type 2 diabetes mellitus: bariatric surgery vs pharmacological therapy4
Lipid status and oxidative stress in menopausal women with obstructive apnea syndrome4
Pneumoconiosises: modern view4
Personalized approach for direct oral anticoagulant prescription: from theory to practice4
Diabetes mellitus and chronic liver diseases. Part 1: general mechanisms of etiology and pathogenesis3
Intestinal manifestations of Behçet's disease3
Endothelial dysfunction in patients with controlled and uncontrolled arterial hypertension3
Underwater rocks of anti - helicobacter therapy3
The efficacy and safety of quadruple therapy without bismuth (concomitant therapy) in the treatment of patients with Helicobacter pylori - associated gastric and duodenal peptic ulcer disease3
Non - tuberculous mycobacteriosis of the lungs - diagnostic possibilities in the practice of the pulmonologist3
Treatment for ventricular arrhythmias in the absence of structural heart disease: from guidelines to clinical practice3
Difficulties and mistakes in the diagnosis of abdominal tuberculosis in the practice of the general practitioner3
10-year risk of fractures (FRAX) in people with diabetes type 23
Relationships of arterial hypertension and reduced renal function in a population 25-45 years3
Features of polymorbidity in cardiac and gastroenterologic patients from a therapeutic clinic3
Cardiovascular syphilis (current state of the problem and analysis of own observations)3
Idiopatic Lobular Panniculitis as a common clinical problem3
Safety of nonsteroidal anti-inflammatory drugs in patients with cardiovascular risk3
Russian multicenter clinical trials in acute leukemias3
A systematic review as a method of gathering scientific evidence into clinical guidelines: CHEST-2019 guideline for the therapy pulmonary arterial hypertension in adults3
Prediction of features of the course of chronic hepatitis C using Bayesian networks3
Human babesiosis: clinical cases in the european part of the Russian Federation3
Early diagnosis of acute renal injury in patients with acute decompensation of chronic heart failure3
Diseases of biliary tract in the context of association with oncological diseases of the digestive system3
Clinical efficacy of acute respiratory viral infections prevention in patients with chronic heart failure3
Thrombotic and hemorrhagic complications in atrial fibrillation patients, undergoing elective percutaneous coronary intervention3
Left ventricular non - compaction: contemporary view of genetic background, clinical course, diagnostic and treatment3
The clinical significance of disorders of the motor function of the esophagus, stomach and duodenum3
Gene therapy of type 2 diabetes mellitus: state of art3
Small intestinal diverticula3
Fibrinolytics: from the thrombolysis to the processes of blood vessels growth and remodeling, neurogenesis, carcinogenesis and fibrosis3
Chronic pain and depression in patients with rheumatoid arthritis: results of five - year follow - up3
Features of central hemodynamics in patients with community - acquired pneumonia depending on the course of the disease and cardiovascular comorbidity3
Levels of depression and life exhaustion in the open population of the middle urbanized Siberian city: gender differences3
Phenotype of obesity and gastroesophageal reflux disease in the context of comorbidity in patients with cardiovascular diseases3
Somatic mutation of the V617F JAK2 gene in patients of the cardiovascular diseases3
Brain MRI-findings in Ph - negative myeloproliferative disorders3
Chronic kidney disease in rheumatoid arthritis patients: prevalence, risks factors, histopathological variants3